Nexgard Combo is a drug owned by BOEHRINGER LNGELHEIM ANIMAL HEALTH USA, INC. It is protected by 7 US drug patents filed from 2026 to 2032. All patents are active. Details of Nexgard Combo’s patents and their expiration are given below.
Exclusivity Information
Nexgard Combo holds 1 exclusivity out of which 0 have expired. Its last outstanding exclusivity is set to expire in 2026. Details of Nexgard Combo's exclusivity codes and their expiration dates are given below.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| NCI | Apr 20, 2026 |
About Nexgard Combo
Nexgard Combo is a drug
owned by BOEHRINGER LNGELHEIM ANIMAL HEALTH USA, INC.
Nexgard Combo uses
Eprinomectin, Esafoxolaner, Praziquantel as the active
ingredients.
Active Ingredient:
Nexgard Combo uses
Eprinomectin,
Esafoxolaner, Praziquantel
as the active ingredients.
Check out other Drugs and Companies using
Eprinomectin, Esafoxolaner, Praziquantel ingredient.